Having more than 150 non-human primates at a research center suffer from diarrhea over two years might not sound like good fortune, but it provided scientists with a treasure trove of immunological data on how to defeat the bacteria responsible for the outbreak.

The study, published in Science Translational Medicine, identified specific parts of the bacteria that the immune system can target effectively. This breakthrough could lead to the rational design of a Shigella vaccine, a critical step in combatting the gastrointestinal horror that afflicts over 200 million people annually, killing more than 200,000, mostly children.

Shigella, a bacterial family, is becoming increasingly resistant to antibiotics, making the need for a sophisticated vaccine even more pressing. The detailed molecular and structural data from the outbreak could be the key to developing a vaccine that can combat the whole clan of bacteria, not just a few serotypes.

The researchers were able to pinpoint the specific antibodies that attach to key molecules within the bacteria, providing a roadmap for vaccine design. This study not only revealed unexpected features of the immune response but also represents a significant step towards a rational vaccine design approach.

While the prospect of 150 primate health issues is far from ideal, the data gathered offers hope for millions affected by Shigella worldwide.